bf/NASDAQ:AGIO_icon.jpeg

COM:AGIOS

Agios Pharmaceuticals, Inc.

  • Stock

Last Close

54.62

21/11 21:00

Market Cap

2.47B

Beta: -

Volume Today

360.45K

Avg: -

Company Information

msh idCOM:AGIOS
symbolAGIO
nameAgios Pharmaceuticals, Inc.
homepage urlhttps://www.agios.com
countryUS
sectorHealthcare
industryBiotechnology
marketSTOCKS
employee count383
crunchbase url-
linkedin url-
founders-

Market Metrics

market cap2.47B
enterprise value-
stage-
raised capital-
valuation-

Web & Growth Metrics

monthly webtraffic-
monthly webtraffic growth-
growth score 14-
growth score 28-
growth score 90-
growth score 365-

LTM & NTM Metrics

revenue ltm-
gross profit ltm-
ebitda ltm-
net income ltm-
revenue ntm-
gross profit ntm-
ebitda ntm-
net income ntm-

Growth & Performance Metrics

growth cost and expenses0.04
growth cost of revenue4.58
growth depreciation and amortization1.05
growth ebitda0.27
growth ebitda ratio0.61
growth eps-
growth eps diluted-
growth general and administrative expenses-
growth gross profit0.38
growth gross profit ratio-0.27

Operating Metrics

cost and expenses418.31M
cost of revenue418.31M
depreciation and amortization6.62M
ebitda-384.86M
ebitda ratio-14.35
eps-6.33
eps diluted-6.33
operating expenses408.81M
operating income-391.49M
operating income ratio-14.6

Balance Sheet Metrics

accounts receivables-604K
capital expenditure-999K
cash at beginning of period139.26M
cash at end of period88.21M
inventory19.08M
working capital ttm702.1M

Financial Metrics (2022-2026)

20222023202420252026
Revenue Metrics
Revenue-----
Revenue Growth-----
Revenue Multiple-----
Profit Metrics
Gross Profit-----
Gross Profit Growth-----
Gross Profit Multiple-----
EBITDA Metrics
EBITDA-----
EBITDA Growth-----
EBITDA Multiple-----
Net Income Metrics
Net Income-----
Net Income Growth-----
Net Income Multiple-----